← 產業報告目錄

Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Workforce, Population Health), End User (Payer, Hospital, ACO, ASC), AI, Market Insights, Trends - Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-01-23頁數 454報告編號 HIT2180

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The healthcare analytics market is expected to grow from USD 55.52 billion in 2025 to USD 166.65 billion by 2030, with a CAGR of 24.6% during the forecast period. The adoption of Electronic Health Records (EHR) is propelling the healthcare analytics market forward. In North America, office-based physicians and non-federal acute care hospitals have adopted EHR systems. There are government incentives available to support EHR systems through the Health Information Technology for Economic and Clinical Health Act. The forces that drive this market include advancements in artificial intelligence, value-based healthcare systems, real-world data, as well as interest in healthcare analytical services by healthcare payers, providers, life sciences companies, and post-acute organizations. “By application, clinical analytics segment is expected to witness the highest growth during the forecast period.” Based on application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operations & administrative analytics, and population health analytics. The clinical analytics segment is growing at the fastest rate during the forecast period driven by increasing adoption of AI-enabled clinical decision support, predictive risk modeling, and real-time patient insights to improve care outcomes, reduce readmissions, and support value-based care initiatives across providers and health system. By component, services segment to witness the highest growth during the forecast period.” Based on component, the healthcare analytics market is segmented into software and services. The clinical analytics segment is growing at the fastest rate during the forecast period driven by rising demand for implementation, system integration, data management, and advanced analytics consulting as healthcare organizations seek to deploy complex AI- and cloud-based analytics platforms while ensuring interoperability, regulatory compliance, and faster time to value. “APAC is estimated to register the highest CAGR during the forecast period.” The healthcare analytics market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare analytics market in Asia Pacific is projected to register the highest CAGR rate during the forecast period. This is driven by rapid EHR penetration, cloud-native deployments, and AI/ML adoption across providers and payers. Increasing use of population health analytics, real-world evidence, and predictive modeling, supported by government-led digital health programs and improving data interoperability standards, is accelerating large-scale analytics implementation across China, India, Japan, and Southeast Asia. In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. • By Company Type: Tier 1 – 45%, Tier 2 – 35%, and Tier 20% • By Designation: C-level Executives – 50%, Directors – 30%, and Others – 20% • By Region: North America– 40%, Europe – 35%, Asia Pacific– 20% and RoW- 5% Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US) are some of the key players in the healthcare analytics market. The study includes an in-depth competitive analysis of these key players in the healthcare analytics market, with their company profiles, recent developments, and key market strategies. Research Coverage The report analyses the healthcare analytics market. It aims to estimate the market size and future growth potential of various market segments based on component, type, application, end-user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies. Reasons to buy this report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare analytics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (favorable government initiatives for electronic health record adoption, growing venture capital investments in startups, need to reduce healthcare costs, increasing focus on real-world evidence, rise of telemedicine and remote patient monitoring, growing focus on regulatory compliance), restraints (hiigh cost of analytics solutions, growing concerns about data breach), opportunities (increasing focus on value-based medicines, growing use of analytics in healthcare, rising number of patient registeries, emergence of social media and digital health technologies), and challenges (concerns regarding inaccurate and inconsistent data, reluctance to adopt healthcare analytics solutions in developing countries, lack of maintenance of medical records, shortage of skilled personnel) influencing the growth of the healthcare analytics market. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare analytics market • Market Development: Comprehensive information about lucrative markets, the report analyses the healthcare analytics market across varied regions. • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare analytics market • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US), Inovalon (US), Mckesson Corporation (US), MedeAnalytics, Inc.(US), Cotiviti, Inc. (US), Exlservice Holdings, Inc. (US), Wipro (India), among others in the healthcare analytics market
目錄 Table of Contents
1 INTRODUCTION 46 1.1 STUDY OBJECTIVES 46 1.2 MARKET DEFINITION 46 1.3 STUDY SCOPE 47 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 47 1.3.2 INCLUSIONS AND EXCLUSIONS 48 1.3.3 YEARS CONSIDERED 48 1.4 CURRENCY CONSIDERED 48 1.5 STAKEHOLDERS 49 1.6 SUMMARY OF CHANGES 50 2 EXECUTIVE SUMMARY 51 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 51 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 52 2.3 DISRUPTIVE TRENDS SHAPING HEALTHCARE ANALYTICS MARKET 53 2.4 HIGH-GROWTH SEGMENTS 54 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 55 3 PREMIUM INSIGHTS 56 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE ANALYTICS MARKET 56 3.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER AND COUNTRY 57 3.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY 58 4 MARKET OVERVIEW 59 4.1 INTRODUCTION 59 4.2 MARKET DYNAMICS 59 4.2.1 DRIVERS 60 4.2.1.1 Favorable government initiatives for electronic health record adoption 60 4.2.1.2 Growing venture capital investments in startups 61 4.2.1.3 Need to reduce healthcare costs 61 4.2.1.4 Increasing focus on real-world evidence 62 4.2.1.5 Rise of telemedicine and remote patient monitoring 63 4.2.1.6 Growing focus on regulatory compliance 63 4.2.2 RESTRAINTS 64 4.2.2.1 High cost of analytics solutions 64 4.2.2.2 Growing concerns about data breaches 65 4.2.3 OPPORTUNITIES 67 4.2.3.1 Increasing focus on value-based medicines 67 4.2.3.2 Growing use of analytics in healthcare 68 4.2.3.3 Rising number of patient registries 68 4.2.3.4 Emergence of social media and digital health technologies 69 4.2.4 CHALLENGES 69 4.2.4.1 Concerns regarding inaccurate and inconsistent data 69 4.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries 70 4.2.4.3 Lack of maintenance of medical records 70 4.2.4.4 Shortage of skilled personnel 71 4.3 UNMET NEEDS AND WHITE SPACES 72 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 72 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 73 5 INDUSTRY TRENDS 75 5.1 PORTER’S FIVE FORCES ANALYSIS 75 5.2 MACROECONOMIC INDICATORS 77 5.2.1 GDP TRENDS AND FORECAST 78 5.2.2 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 78 5.3 VALUE CHAIN ANALYSIS 79 5.4 ECOSYSTEM ANALYSIS 80 5.5 PRICING ANALYSIS 82 5.5.1 INDICATIVE PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT 82 5.5.2 INDICATIVE PRICING, BY REGION 83 5.6 KEY CONFERENCES AND EVENTS, 2026–2027 84 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 85 5.8 INVESTMENT AND FUNDING SCENARIO 85 5.9 CASE STUDY ANALYSIS 86 5.10 IMPACT OF 2025 US TARIFF – HEALTHCARE ANALYTICS MARKET 88 5.10.1 KEY TARIFF RATES 89 5.10.2 PRICE IMPACT ANALYSIS 90 5.10.3 IMPACT ON COUNTRIES/REGIONS 90 5.10.3.1 US 90 5.10.3.2 Europe 91 5.10.3.3 Asia Pacific 91 5.10.4 IMPACT ON END-USE INDUSTRY 91 5.10.4.1 Healthcare providers 91 5.10.4.1.1 Hospitals & health systems 91 5.10.4.1.2 Physician groups & clinics 92 5.10.4.1.3 Ambulatory surgery centers (ASCs) 92 5.10.4.2 Healthcare payers 92 5.10.4.2.1 Private insurance companies 92 5.10.4.2.2 Government payers 92 5.10.4.3 Pharmacies 92 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 93 6.1 TECHNOLOGY ANALYSIS 93 6.1.1 KEY TECHNOLOGIES 93 6.1.1.1 Big data analytics 93 6.1.1.2 Artificial intelligence and machine learning 94 6.1.1.3 Business intelligence tools 94 6.1.2 COMPLEMENTARY TECHNOLOGIES 94 6.1.2.1 Cloud computing and data integration platforms 94 6.1.2.2 Interoperability frameworks and APIs 95 6.1.3 ADJACENT TECHNOLOGIES 95 6.1.3.1 Cloud computing 95 6.1.3.2 Internet of Things 95 6.2 TECHNOLOGY/PRODUCT ROADMAP 96 6.3 PATENT ANALYSIS 97 6.3.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ANALYTICS MARKET 97 6.3.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 98 6.4 FUTURE APPLICATIONS 101 6.4.1 AI-DRIVEN PREDICTIVE ANALYTICS AND CLINICAL DECISION SUPPORT 101 6.4.2 REAL-WORLD EVIDENCE (RWE) AND CLINICAL RESEARCH TRANSFORMATION 101 6.4.3 OPERATIONAL INTELLIGENCE AND HEALTHCARE SYSTEM OPTIMIZATION 101 6.5 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET 101 6.5.1 MARKET POTENTIAL OF AI/GEN AI 102 6.5.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN HEALTHCARE ANALYTICS MARKET 103 6.5.2.1 AI-driven continuous glucose monitoring and diabetes management 103 6.5.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 104 6.5.3.1 Clinical development & decentralized trials 104 6.5.3.2 Digital biomarkers & endpoint innovation 105 6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN HEALTHCARE ANALYTICS MARKET 105 6.5.4.1 User readiness 105 6.5.4.1.1 User A: Hospitals, clinics & long-term care providers 105 6.5.4.1.2 User B: Pharma and biotech companies 105 6.5.4.2 Impact assessment 105 6.5.4.2.1 User A: Hospitals, clinics & long-term care providers 105 6.5.4.2.1.1 Implementation 105 6.5.4.2.1.2 Impact 106 6.5.4.2.2 User B: Healthcare payers 106 6.5.4.2.2.1 Implementation 106 6.5.4.2.2.2 Impact 106 7 REGULATORY LANDSCAPE 107 7.1 REGIONAL REGULATIONS AND COMPLIANCE 107 7.1.1 GOVERNMENT REGULATIONS 110 7.1.1.1 US 110 7.1.1.2 Europe 110 7.1.1.3 China 110 7.1.1.4 Japan 111 7.1.1.5 India 111 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 7.1.3 INDUSTRY STANDARDS 114 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 115 8.1 DECISION-MAKING PROCESS 115 8.2 KEY STAKEHOLDERS IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 116 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 116 8.2.2 BUYING CRITERIA 117 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 118 8.4 UNMET NEEDS FROM END-USE INDUSTRIES 118 8.4.1 UNMET NEEDS 119 8.4.2 END-USER EXPECTATIONS 120 8.5 MARKET PROFITABILITY 120 9 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 122 9.1 INTRODUCTION 123 9.2 SERVICES 123 9.2.1 MANAGED SERVICES 125 9.2.1.1 Analytics operations 127 9.2.1.1.1 Continuous performance monitoring reshapes managed analytics delivery models 127 9.2.1.2 Infrastructure & cloud management 128 9.2.1.2.1 Cloud-native infrastructure services underpin healthcare analytics scalability 128 9.2.2 PROFESSIONAL SERVICES 129 9.2.2.1 Training & education 131 9.2.2.1.1 Workforce upskilling becomes critical enabler of analytics transformation 131 9.2.2.2 Implementation & integration 132 9.2.2.2.1 Interoperability mandates catalyze complex analytics integration engagements 132 9.2.2.3 Consulting 133 9.2.2.3.1 Strategic data governance consulting unlocks organizational analytics readiness 133 9.2.2.4 Support & maintenance 134 9.2.2.4.1 Post-deployment support sustains long-term analytics performance and compliance 134 9.3 SOFTWARE 135 9.3.1 POINT ANALYTICS SOLUTIONS 137 9.3.1.1 Targeted problem-solving drives rapid adoption of specialized analytics tools 137 9.3.2 ENTERPRISE-WIDE ANALYTICS PLATFORMS 138 9.3.2.1 Unified data platforms enable cross-continuum analytics at enterprise scale 138 10 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL 140 10.1 INTRODUCTION 141 10.2 ON-PREMISES 141 10.3 CLOUD-BASED 142 11 HEALTHCARE ANALYTICS MARKET, BY TYPE 144 11.1 INTRODUCTION 145 11.2 DESCRIPTIVE ANALYTICS 145 11.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET 145 11.3 PREDICTIVE ANALYTICS 147 11.3.1 AI-POWERED RISK MODELS TRANSFORM PROACTIVE CLINICAL AND OPERATIONAL PLANNING 147 11.4 PRESCRIPTIVE ANALYTICS 150 11.4.1 NEXT-BEST-ACTION OPTIMIZATION ELEVATES ANALYTICS FROM INSIGHT TO AUTOMATED INTERVENTION 150 11.5 DIAGNOSTIC ANALYTICS 151 11.5.1 ROOT-CAUSE INTELLIGENCE DRIVES SYSTEMATIC QUALITY AND COST PERFORMANCE IMPROVEMENT 151 12 HEALTHCARE ANALYTICS MARKET, BY APPLICATION 153 12.1 INTRODUCTION 154 12.2 FINANCIAL ANALYTICS 154 12.2.1 CLAIMS ANALYTICS 156 12.2.1.1 Automated claims intelligence reduces revenue leakage and administrative burden 156 12.2.2 REVENUE CYCLE MANAGEMENT 157 12.2.2.1 End-to-end revenue intelligence optimizes margins across care continuum 157 12.2.3 FRAUD, WASTE, & ABUSE ANALYTICS 159 12.2.3.1 AI-powered detection frameworks reduce healthcare fraud and improper payments 159 12.2.4 RISK ADJUSTMENT & PAYMENT INTEGRITY 160 12.2.4.1 Accurate risk coding drives financial sustainability in value-based health plans 160 12.3 CLINICAL ANALYTICS 162 12.3.1 CLINICAL DECISION SUPPORT 164 12.3.1.1 Real-time evidence delivery at point of care transforms clinical outcomes 164 12.3.2 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING 166 12.3.2.1 National quality benchmarks propel data-driven performance accountability 166 12.3.3 MEDICAL IMAGING ANALYTICS 167 12.3.3.1 AI-augmented imaging analysis accelerates diagnostic throughput and accuracy 167 12.3.4 REMOTE PATIENT MONITORING ANALYTICS 168 12.3.4.1 Wearable data integration expands longitudinal analytics beyond clinical walls 168 12.3.5 PRECISION HEALTH ANALYTICS 170 12.3.5.1 Genomic and multi-omics data convergence enables personalized care delivery 170 12.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS 171 12.4.1 SUPPLY CHAIN ANALYTICS 173 12.4.1.1 Predictive supply intelligence mitigates healthcare cost and shortage risks 173 12.4.2 WORKFORCE ANALYTICS 174 12.4.2.1 Predictive staffing models address healthcare talent shortages and labor costs 174 12.4.3 STRATEGIC ANALYTICS 175 12.4.3.1 Real-time visibility optimizes patient flow across complex care environments 175 12.4.4 CAPACITY & WORKFLOW ANALYTICS 177 12.4.4.1 Rising adoption of capacity & workflow analytics 177 12.5 POPULATION HEALTH ANALYTICS 177 12.5.1 CHRONIC DISEASE MANAGEMENT 179 12.5.1.1 Implementing predictive analytics for early identification and proactive management of high-risk chronic disease patients 179 12.5.2 PREVENTIVE CARE ANALYTICS 180 12.5.2.1 Screening gap identification drives proactive population wellness interventions 180 12.5.3 VALUE-BASED CARE ANALYTICS 181 12.5.3.1 Total cost of care intelligence enables sustainable value-based contract performance 181 12.5.4 RISK STRATIFICATION 182 12.5.4.1 Predictive scoring models enable precision targeting of high-risk individuals 182   12.6 PATIENT JOURNEY & ENGAGEMENT ANALYTICS 183 12.6.1 PATIENT COMMUNICATION & OUTREACH ANALYTICS 185 12.6.1.1 Multichannel analytics optimizes outreach precision and patient response rates 185 12.6.2 PATIENT ADHERENCE ANALYTICS 186 12.6.2.1 Behavioral data insights drive targeted interventions to improve treatment compliance 186 12.6.3 PATIENT EXPERIENCE ANALYTICS 187 12.6.3.1 Satisfaction intelligence transforms patient-centered care accountability 187 13 HEALTHCARE ANALYTICS MARKET, BY END USER 189 13.1 INTRODUCTION 190 13.2 HEALTHCARE PROVIDERS 190 13.2.1 HOSPITALS & HEALTH SYSTEMS 192 13.2.1.1 Enterprise analytics integration drives system-wide performance accountability 192 13.2.2 PHYSICIAN GROUPS & CLINICS 193 13.2.2.1 Value-based contracts drive analytics adoption in ambulatory care settings 193 13.2.3 AMBULATORY SURGERY CENTERS 194 13.2.3.1 Operational transparency and quality metrics drive ASC Analytics investment 194 13.2.4 OTHER PROVIDERS 195 13.3 HEALTHCARE PAYERS 196 13.3.1 PRIVATE INSURANCE COMPANIES 198 13.3.1.1 Actuarial intelligence and member analytics sustain commercial plan competitiveness 198 13.3.2 GOVERNMENT PAYERS 199 13.3.2.1 Federal efficiency mandates accelerate analytics in public payer programs 199 13.3.3 OTHER PAYERS 200 13.4 PHARMACIES 202 13.5 OTHER END USERS 203 14 HEALTHCARE ANALYTICS MARKET, BY REGION 205 14.1 INTRODUCTION 206 14.2 NORTH AMERICA 206 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 207 14.2.2 US 215 14.2.2.1 High adoption of electronic health records to drive market 215 14.2.3 CANADA 223 14.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market 223   14.3 EUROPE 230 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 231 14.3.2 GERMANY 238 14.3.2.1 Government initiatives to increase use of analytics in healthcare to drive market 238 14.3.3 UK 245 14.3.3.1 Availability of venture capital investments to drive market 245 14.3.4 FRANCE 252 14.3.4.1 Strong financial support for digital health to augment market 252 14.3.5 ITALY 260 14.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions 260 14.3.6 SPAIN 267 14.3.6.1 Growing adoption of personalized medicine to drive market 267 14.3.7 REST OF EUROPE 273 14.4 ASIA PACIFIC 281 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 281 14.4.2 JAPAN 289 14.4.2.1 Rising geriatric population to drive demand for effective patient management solutions 289 14.4.3 CHINA 296 14.4.3.1 Favorable reforms and growing number of electronic health records to aid market growth 296 14.4.4 INDIA 303 14.4.4.1 Favorable government initiatives to fuel market 303 14.4.5 AUSTRALIA 311 14.4.5.1 Strong digital health ecosystem and government-led initiatives to drive healthcare analytics adoption 311 14.4.6 SOUTH KOREA 318 14.4.6.1 Favorable government initiatives and strong digital health ecosystem to fuel market growth 318 14.4.7 REST OF ASIA PACIFIC 326 14.5 LATIN AMERICA 334 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 334 14.5.2 BRAZIL 341 14.5.2.1 Growing adoption of digital solutions in healthcare to boost market 341 14.5.3 MEXICO 349 14.5.3.1 Growing prominence of startups and rising R&D activity to propel market 349 14.5.4 REST OF LATIN AMERICA 356 14.6 MIDDLE EAST & AFRICA 363 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 363 14.6.2 GCC COUNTRIES 367 14.6.2.1 Rising investments and developing healthcare infrastructure to drive market 367 14.6.3 SAUDI ARABIA 375 14.6.3.1 Strong government-led digital health transformation to fuel market 375 14.6.4 UAE 382 14.6.4.1 Strong government-led digital health transformation to drive market 382 14.6.5 REST OF GCC COUNTRIES 389 14.6.5.1 Strong government-led digital health transformation to fuel market 389 14.6.6 SOUTH AFRICA 396 14.6.6.1 Favorable government-led digital health transformation and rising disease burden to fuel market 396 14.6.7 REST OF MIDDLE EAST & AFRICA 403 15 COMPETITIVE LANDSCAPE 411 15.1 INTRODUCTION 411 15.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–2026 411 15.3 REVENUE ANALYSIS, 2021–2025 412 15.4 MARKET SHARE ANALYSIS, 2025 413 15.5 BRAND/SOFTWARE COMPARISON 417 15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 418 15.6.1 STARS 418 15.6.2 EMERGING LEADERS 418 15.6.3 PERVASIVE PLAYERS 418 15.6.4 PARTICIPANTS 418 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 420 15.6.5.1 Company footprint 420 15.6.5.2 Region footprint 421 15.6.5.3 Component footprint 422 15.6.5.4 Application footprint 423 15.6.5.5 End user footprint 424 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 425 15.7.1 PROGRESSIVE COMPANIES 425 15.7.2 RESPONSIVE COMPANIES 425 15.7.3 DYNAMIC COMPANIES 425 15.7.4 STARTING BLOCKS 425 15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 427 15.7.5.1 Detailed list of key startups/SMEs 427 15.7.5.2 Competitive benchmarking of key startups/SMEs 428 15.8 COMPANY VALUATION AND FINANCIAL METRICS 428 15.9 COMPETITIVE SCENARIO 429 15.9.1 PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 429 15.9.2 DEALS 431 15.9.3 EXPANSIONS 432 16 COMPANY PROFILES 433 16.1 KEY PLAYERS 433 16.1.1 MERATIVE 433 16.1.1.1 Business overview 433 16.1.1.2 Products/Solutions/Services offered 434 16.1.1.3 Recent developments 434 16.1.1.3.1 Product launches/enhancements/approvals 434 16.1.1.3.2 Deals 435 16.1.1.4 MnM view 435 16.1.1.4.1 Right to Win 435 16.1.1.4.2 Strategic choices 436 16.1.1.4.3 Weaknesses and competitive threats 436 16.1.2 SAS INSTITUTE INC. 437 16.1.2.1 Business overview 437 16.1.2.2 Products/Solutions/Services offered 438 16.1.2.3 Recent developments 439 16.1.2.3.1 Product launches/enhancements/approvals 439 16.1.2.4 MnM view 440 16.1.2.4.1 Right to Win 440 16.1.2.4.2 Strategic choices 440 16.1.2.4.3 Weaknesses and competitive threats 441 16.1.3 OPTUM, INC. 442 16.1.3.1 Business overview 442 16.1.3.2 Products/Solutions/Services offered 443 16.1.3.3 Recent developments 445 16.1.3.3.1 Product launches and approvals 445 16.1.3.3.2 Deals 446 16.1.3.4 MnM view 446 16.1.3.4.1 Right to Win 446 16.1.3.4.2 Strategic choices 447 16.1.3.4.3 Weaknesses and competitive threats 447 16.1.4 ORACLE 448 16.1.4.1 Business overview 448 16.1.4.2 Products/Solutions/Services offered 450 16.1.4.3 Recent developments 452 16.1.4.3.1 Product launches/enhancements/approvals 452 16.1.4.3.2 Deals 453 16.1.4.4 MnM view 454 16.1.4.4.1 Right to Win 454 16.1.4.4.2 Strategic choices 454 16.1.4.4.3 Weaknesses and competitive threats 455   16.1.5 HEALTH CATALYST 456 16.1.5.1 Business overview 456 16.1.5.2 Products/Solutions/Services offered 457 16.1.5.3 Recent developments 458 16.1.5.3.1 Product launches/enhancements/approvals 458 16.1.5.3.2 Deals 460 16.1.5.4 MnM view 460 16.1.5.4.1 Right to Win 460 16.1.5.4.2 Strategic choices 461 16.1.5.4.3 Weaknesses and competitive threats 461 16.1.6 EXLSERVICE HOLDINGS, INC. 462 16.1.6.1 Business overview 462 16.1.6.2 Products/Solutions/Services offered 463 16.1.6.3 Recent developments 465 16.1.6.3.1 Deals 465 16.1.6.3.2 Other developments 465 16.1.6.4 MnM view 465 16.1.6.4.1 Right to Win 465 16.1.6.4.2 Strategic choices 466 16.1.6.4.3 Weaknesses and competitive threats 466 16.1.7 VERADIGM LLC 467 16.1.7.1 Business overview 467 16.1.7.2 Products/Solutions/Services offered 469 16.1.7.3 Recent developments 470 16.1.7.3.1 Product launches/enhancements/approvals 470 16.1.7.3.2 Deals 471 16.1.7.3.3 Other developments 472 16.1.7.4 MnM view 472 16.1.7.4.1 Right to Win 472 16.1.7.4.2 Strategic choices 472 16.1.7.4.3 Weaknesses and competitive threats 473 16.1.8 CITIUSTECH INC. 474 16.1.8.1 Business overview 474 16.1.8.2 Products/Solutions/Services offered 475 16.1.8.3 Recent developments 475 16.1.8.3.1 Product launches/enhancements/approvals 475 16.1.8.3.2 Deals 476 16.1.8.3.3 Expansions 476 16.1.9 CVS HEALTH 477 16.1.9.1 Business overview 477 16.1.9.2 Products/Solutions/Services offered 478 16.1.9.3 Recent developments 479 16.1.9.3.1 Product launches/enhancements/approvals 479 16.1.9.3.2 Deals 479 16.1.10 INOVALON 481 16.1.10.1 Business overview 481 16.1.10.2 Products/Solutions/Services offered 482 16.1.10.3 Recent developments 483 16.1.10.3.1 Product launches/enhancements/approvals 483 16.1.10.3.2 Deals 483 16.1.10.3.3 Expansions 484 16.1.10.3.4 Other developments 484 16.1.11 MCKESSON CORPORATION 485 16.1.11.1 Business overview 485 16.1.11.2 Products/Solutions/Services offered 486 16.1.11.3 Recent developments 487 16.1.11.3.1 Deals 487 16.1.12 MEDEANALYTICS, INC. 488 16.1.12.1 Business overview 488 16.1.12.2 Products/Solutions/Services offered 489 16.1.12.3 Recent developments 490 16.1.12.3.1 Deals 490 16.1.13 COTIVITI, INC. 491 16.1.13.1 Business overview 491 16.1.13.2 Products/Solutions/Services offered 492 16.1.14 DATAVANT, INC. 493 16.1.14.1 Business overview 493 16.1.14.2 Products/Solutions/Services offered 494 16.1.14.3 Recent developments 495 16.1.14.3.1 Product launches/enhancements/approvals 495 16.1.14.3.2 Deals 495 16.1.15 DEFINITIVE HEALTHCARE, LLC 497 16.1.15.1 Business overview 497 16.1.15.2 Products/Solutions/Services offered 498 16.1.15.3 Recent developments 499 16.1.15.3.1 Product launches/enhancements/approvals 499 16.1.15.3.2 Deals 500 16.1.16 KOMODO HEALTH, INC. 501 16.1.16.1 Business overview 501 16.1.16.2 Products/Solutions/Services offered 502 16.1.16.3 Recent developments 502 16.1.16.3.1 Product launches/enhancements/approvals 502 16.1.16.3.2 Deals 503   16.1.17 ATHENAHEALTH, INC. 504 16.1.17.1 Business overview 504 16.1.17.2 Products/Solutions/Services offered 505 16.1.17.3 Recent developments 505 16.1.17.3.1 Product launches/enhancements/approvals 505 16.1.17.3.2 Deals 507 16.1.18 IQVIA 508 16.1.18.1 Business overview 508 16.1.18.2 Products/Solutions/Services offered 509 16.1.18.3 Recent developments 510 16.1.18.3.1 Product launches/enhancements/approvals 510 16.1.18.3.2 Deals 511 16.1.19 WIPRO 512 16.1.19.1 Business overview 512 16.1.19.2 Products/Solutions/Services offered 513 16.1.20 CLOUDERA, INC. 514 16.1.20.1 Business overview 514 16.1.20.2 Products/Solutions/Services offered 515 16.1.20.3 Recent developments 516 16.1.20.3.1 Product launches/enhancements/approvals 516 16.1.20.3.2 Deals 517 16.2 OTHER PLAYERS 518 16.2.1 HEALTHVERITY, INC. 518 16.2.2 KYRUUS, INC. 518 16.2.3 HEALTHCORUM 519 16.2.4 LUMA HEALTH INC. 519 16.2.5 VALIDIC, INC. 520 17 RESEARCH METHODOLOGY 521 17.1 RESEARCH APPROACH 521 17.1.1 SECONDARY RESEARCH 522 17.1.1.1 Key data from secondary sources 523 17.1.2 PRIMARY RESEARCH 523 17.1.2.1 Primary sources 524 17.1.2.2 Key data from primary sources 525 17.1.2.3 Breakdown of primary interviews 525 17.1.2.4 Insights from primary experts 526 17.2 RESEARCH METHODOLOGY DESIGN 526 17.3 MARKET SIZE ESTIMATION 527 17.4 DATA TRIANGULATION 532 17.5 RESEARCH ASSUMPTIONS 533 17.6 RESEARCH LIMITATIONS 534 17.6.1 METHODOLOGY-RELATED 534 17.6.2 SCOPE-RELATED 534 17.7 RISK ASSESSMENT 535 18 APPENDIX 536 18.1 DISCUSSION GUIDE 536 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 541 18.3 CUSTOMIZATION OPTIONS 543 18.4 RELATED REPORTS 543 18.5 AUTHOR DETAILS 544
圖表清單 List of Tables & Figures
TABLE 1 USD EXCHANGE RATES 49 TABLE 2 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES, 2023–2024 67 TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON HEALTHCARE ANALYTICS MARKET 76 TABLE 4 ROLE OF COMPANIES IN ECOSYSTEM 81 TABLE 5 INDICATIVE PRICING OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT 82 TABLE 6 INDICATIVE PRICING OF ANALYTICS SOLUTIONS, BY REGION 84 TABLE 7 HEALTHCARE ANALYTICS MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 84 TABLE 8 ADOPTION OF HEALTH CATALYST DATA OPERATING SYSTEM FOR IMPROVED ANNUAL SAVINGS 86 TABLE 9 USE OF COMPREHENSIVE DATA ANALYTICS PLATFORM TO MEET NEEDS OF EVOLVING HEALTHCARE ENVIRONMENT 87 TABLE 10 CLINICAL DECISION-MAKING PROCESS IMPROVEMENT WITH DATA OPERATING SYSTEM PLATFORM 88 TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 89 TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE ANALYTICS MARKET 99 TABLE 13 HEALTHCARE ANALYTICS MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2015–2026 100 TABLE 14 NORTH AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 107 TABLE 15 EUROPE: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 108 TABLE 16 ASIA PACIFIC: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 108 TABLE 17 MIDDLE EAST & AFRICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 109 TABLE 18 LATIN AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 110 TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 22 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113 TABLE 23 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 117 TABLE 25 KEY BUYING CRITERIA, BY END USER 118 TABLE 26 UNMET NEEDS IN HEALTHCARE ANALYTICS MARKET 119 TABLE 27 END-USER EXPECTATIONS IN HEALTHCARE ANALYTICS MARKET 120 TABLE 28 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 123 TABLE 29 HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 30 HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 125 TABLE 31 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2024–2031 (USD MILLION) 126 TABLE 32 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY REGION, 2024–2031 (USD MILLION) 126 TABLE 33 HEALTHCARE ANALYTICS MARKET FOR ANALYTICS OPERATIONS, BY REGION, 2024–2031 (USD MILLION) 128 TABLE 34 HEALTHCARE ANALYTICS MARKET FOR INFRASTRUCTURE & CLOUD MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 129 TABLE 35 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2024–2031 (USD MILLION) 130 TABLE 36 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY REGION, 2024–2031 (USD MILLION) 130 TABLE 37 HEALTHCARE ANALYTICS MARKET FOR TRAINING & EDUCATION, BY REGION, 2024–2031 (USD MILLION) 131 TABLE 38 HEALTHCARE ANALYTICS MARKET FOR IMPLEMENTATION & INTEGRATION, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 39 HEALTHCARE ANALYTICS MARKET FOR CONSULTING, BY REGION, 2024–2031 (USD MILLION) 134 TABLE 40 HEALTHCARE ANALYTICS MARKET FOR SUPPORT & MAINTENANCE, BY REGION, 2024–2031 (USD MILLION) 135 TABLE 41 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 42 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 43 HEALTHCARE ANALYTICS MARKET FOR POINT ANALYTICS SOLUTIONS, BY REGION, 2024–2031 (USD MILLION) 138 TABLE 44 HEALTHCARE ANALYTICS MARKET FOR ENTERPRISE-WIDE ANALYTICS PLATFORMS, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 45 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 141 TABLE 46 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISES, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 47 HEALTHCARE ANALYTICS MARKET FOR CLOUD-BASED, BY REGION, 2024–2031 (USD MILLION) 143 TABLE 48 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 145 TABLE 49 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 50 APPLICATIONS OF PREDICTIVE ANALYTICS 148 TABLE 51 COMMERCIALLY AVAILABLE PREDICTIVE ANALYTICS SOLUTIONS 149 TABLE 52 PREDICTIVE ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 149 TABLE 53 COMMERCIALLY AVAILABLE PRESCRIPTIVE ANALYTICS SOLUTIONS 150 TABLE 54 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 55 DIAGNOSTIC ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 152 TABLE 56 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 154 TABLE 57 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS 155 TABLE 58 FINANCIAL ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 155 TABLE 59 FINANCIAL ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 60 COMMERCIALLY AVAILABLE CLAIMS ANALYTICS SOLUTIONS 157 TABLE 61 FINANCIAL ANALYTICS MARKET FOR CLAIMS ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 157 TABLE 62 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS 158 TABLE 63 FINANCIAL ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 159 TABLE 64 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS 160 TABLE 65 FINANCIAL ANALYTICS MARKET FOR FRAUD, WASTE, AND ABUSE ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 160 TABLE 66 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS 161 TABLE 67 FINANCIAL ANALYTICS MARKET FOR RISK ADJUSTMENT & PAYMENT INTEGRITY, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 68 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS 163 TABLE 69 CLINICAL ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 163 TABLE 70 CLINICAL ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 164 TABLE 71 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS 165 TABLE 72 CLINICAL ANALYTICS MARKET FOR CLINICAL DECISION SUPPORT, BY REGION, 2024–2031 (USD MILLION) 165 TABLE 73 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT 166 TABLE 74 CLINICAL ANALYTICS MARKET FOR QUALITY IMPROVEMENT & CLINICAL BENCHMARKING, BY REGION, 2024–2031 (USD MILLION) 167 TABLE 75 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE 168 TABLE 76 CLINICAL ANALYTICS MARKET FOR MEDICAL IMAGING ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 168 TABLE 77 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS 169 TABLE 78 CLINICAL ANALYTICS MARKET FOR REMOTE PATIENT MONITORING ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 169 TABLE 79 COMMERCIALLY AVAILABLE PRECISION HEALTH/REAL-WORLD EVIDENCE SOLUTIONS 170 TABLE 80 CLINICAL ANALYTICS MARKET FOR PRECISION HEALTH ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 81 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS 172 TABLE 82 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 172 TABLE 83 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 172 TABLE 84 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS 173 TABLE 85 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 86 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS 175 TABLE 87 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR WORKFORCE ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 88 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR STRATEGIC ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 176 TABLE 89 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR CAPACITY & WORKFLOW ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 90 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS 178 TABLE 91 POPULATION HEALTH ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 178 TABLE 92 POPULATION HEALTH ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 179 TABLE 93 POPULATION HEALTH ANALYTICS MARKET FOR CHRONIC DISEASE MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 180 TABLE 94 POPULATION HEALTH ANALYTICS MARKET FOR PREVENTIVE CARE ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 181 TABLE 95 POPULATION HEALTH ANALYTICS MARKET FOR VALUE-BASED CARE ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 96 POPULATION HEALTH ANALYTICS MARKET FOR RISK STRATIFICATION, BY REGION, 2024–2031 (USD MILLION) 183 TABLE 97 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 184 TABLE 98 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 185 TABLE 99 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET FOR PATIENT COMMUNICATION & OUTREACH ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 186 TABLE 100 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET FOR PATIENT ADHERENCE ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 187 TABLE 101 PATIENT JOURNEY & ENGAGEMENT ANALYTICS MARKET FOR PATIENT EXPERIENCE ANALYTICS, BY REGION, 2024–2031 (USD MILLION) 188 TABLE 102 HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 190 TABLE 103 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 191 TABLE 104 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 105 HEALTHCARE ANALYTICS MARKET FOR HOSPITALS & HEALTH SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 193 TABLE 106 HEALTHCARE ANALYTICS MARKET FOR PHYSICIAN GROUPS & CLINICS, BY REGION, 2024–2031 (USD MILLION) 194 TABLE 107 HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 108 HEALTHCARE ANALYTICS MARKET FOR OTHER PROVIDERS, BY REGION, 2024–2031 (USD MILLION) 196 TABLE 109 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 197 TABLE 110 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PAYERS, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 111 HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 199 TABLE 112 HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT PAYERS, BY REGION, 2024–2031 (USD MILLION) 200 TABLE 113 HEALTHCARE ANALYTICS MARKET FOR OTHER PAYERS, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 114 HEALTHCARE ANALYTICS MARKET FOR PHARMACIES, BY REGION, 2024–2031 (USD MILLION) 202 TABLE 115 HEALTHCARE ANALYTICS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 204 TABLE 116 HEALTHCARE ANALYTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 206 TABLE 117 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 118 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 209 TABLE 119 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 209 TABLE 120 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 209 TABLE 121 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 210 TABLE 122 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 210 TABLE 123 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 210 TABLE 124 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 125 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 211 TABLE 126 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 212 TABLE 127 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 212 TABLE 128 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 213 TABLE 129 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 213 TABLE 130 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 214 TABLE 131 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 214 TABLE 132 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 215 TABLE 133 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 215 TABLE 134 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 216 TABLE 135 US: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 217 TABLE 136 US: HEALTHCARE ANALYTICS MARKET, BY SERVICE 2024–2031 (USD MILLION) 217 TABLE 137 US: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE 2024–2031 (USD MILLION) 217 TABLE 138 US: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE 2024–2031 (USD MILLION) 218 TABLE 139 US: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT 2024–2031 (USD MILLION) 218 TABLE 140 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 141 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219 TABLE 142 US: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 219 TABLE 143 US: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 220 TABLE 144 US: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 220 TABLE 145 US: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 221 TABLE 146 US: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 221 TABLE 147 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 222 TABLE 148 US: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 222 TABLE 149 US: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 222 TABLE 150 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 224 TABLE 151 CANADA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 224 TABLE 152 CANADA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 224 TABLE 153 CANADA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 225 TABLE 154 CANADA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 225 TABLE 155 CANADA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 225 TABLE 156 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 157 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 226 TABLE 158 CANADA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 227 TABLE 159 CANADA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 227 TABLE 160 CANADA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 228 TABLE 161 CANADA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 228 TABLE 162 CANADA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 229 TABLE 163 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 229 TABLE 164 CANADA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 230 TABLE 165 CANADA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 230 TABLE 166 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 167 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 232 TABLE 168 EUROPE: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 232 TABLE 169 EUROPE: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 233 TABLE 170 EUROPE: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 233 TABLE 171 EUROPE: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 233 TABLE 172 EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 234 TABLE 173 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 174 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 234 TABLE 175 EUROPE: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 235 TABLE 176 EUROPE: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 235 TABLE 177 EUROPE: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 236 TABLE 178 EUROPE: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 236 TABLE 179 EUROPE: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 237 TABLE 180 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 237 TABLE 181 EUROPE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 238 TABLE 182 EUROPE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 238 TABLE 183 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 239 TABLE 184 GERMANY: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 239 TABLE 185 GERMANY: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 240 TABLE 186 GERMANY: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 240 TABLE 187 GERMANY: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 240 TABLE 188 GERMANY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 241 TABLE 189 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 241 TABLE 190 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 241 TABLE 191 GERMANY: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 242 TABLE 192 GERMANY: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 242 TABLE 193 GERMANY: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 243 TABLE 194 GERMANY: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 243 TABLE 195 GERMANY: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 244 TABLE 196 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 244 TABLE 197 GERMANY: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 245 TABLE 198 GERMANY: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 245 TABLE 199 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 246 TABLE 200 UK: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 246 TABLE 201 UK: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 247 TABLE 202 UK: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 247 TABLE 203 UK: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 247 TABLE 204 UK: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 248 TABLE 205 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 206 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 248 TABLE 207 UK: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 249 TABLE 208 UK: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 249 TABLE 209 UK: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 250 TABLE 210 UK: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 250 TABLE 211 UK: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 251 TABLE 212 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 251 TABLE 213 UK: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 252 TABLE 214 UK: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 252 TABLE 215 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 253 TABLE 216 FRANCE: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 253 TABLE 217 FRANCE: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 254 TABLE 218 FRANCE: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 254 TABLE 219 FRANCE: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 254 TABLE 220 FRANCE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 255 TABLE 221 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 222 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 256 TABLE 223 FRANCE: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 256 TABLE 224 FRANCE: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 257 TABLE 225 FRANCE: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 257 TABLE 226 FRANCE: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 258 TABLE 227 FRANCE: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 258 TABLE 228 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 259 TABLE 229 FRANCE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 259 TABLE 230 FRANCE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 259 TABLE 231 ITALY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 260 TABLE 232 ITALY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT FOR SOFTWARE, 2024–2031 (USD MILLION) 261 TABLE 233 ITALY: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 261 TABLE 234 ITALY: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 261 TABLE 235 ITALY: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 262 TABLE 236 ITALY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 262 TABLE 237 ITALY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 238 ITALY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 263 TABLE 239 ITALY: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 263 TABLE 240 ITALY: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 264 TABLE 241 ITALY: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 264 TABLE 242 ITALY: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 265 TABLE 243 ITALY: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 265 TABLE 244 ITALY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 266 TABLE 245 ITALY: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 266 TABLE 246 ITALY: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 266 TABLE 247 SPAIN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 267 TABLE 248 SPAIN: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 267 TABLE 249 SPAIN: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 268 TABLE 250 SPAIN: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 268 TABLE 251 SPAIN: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 268 TABLE 252 SPAIN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 269 TABLE 253 SPAIN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 254 SPAIN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 269 TABLE 255 SPAIN: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 270 TABLE 256 SPAIN: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 270 TABLE 257 SPAIN: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 271 TABLE 258 SPAIN: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 271 TABLE 259 SPAIN: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 272 TABLE 260 SPAIN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 272 TABLE 261 SPAIN: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 273 TABLE 262 SPAIN: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 273 TABLE 263 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 274 TABLE 264 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 274 TABLE 265 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 274 TABLE 266 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 275 TABLE 267 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 275 TABLE 268 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 275 TABLE 269 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 270 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 276 TABLE 271 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 277 TABLE 272 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 277 TABLE 273 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 278 TABLE 274 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 278 TABLE 275 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 279 TABLE 276 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 279 TABLE 277 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 280 TABLE 278 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 280 TABLE 279 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 280 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 283 TABLE 281 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 283 TABLE 282 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 284 TABLE 283 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 284 TABLE 284 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 284 TABLE 285 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 285 TABLE 286 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 287 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 285 TABLE 288 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 286 TABLE 289 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 286 TABLE 290 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 287 TABLE 291 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 287 TABLE 292 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 288 TABLE 293 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 288 TABLE 294 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 289 TABLE 295 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 289 TABLE 296 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 290 TABLE 297 JAPAN: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 290 TABLE 298 JAPAN: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 290 TABLE 299 JAPAN: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 291 TABLE 300 JAPAN: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 291 TABLE 301 JAPAN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 291 TABLE 302 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE 2024–2031 (USD MILLION) 292 TABLE 303 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 292 TABLE 304 JAPAN: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 293 TABLE 305 JAPAN: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 293 TABLE 306 JAPAN: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 294 TABLE 307 JAPAN: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 294 TABLE 308 JAPAN: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 295 TABLE 309 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 295 TABLE 310 JAPAN: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 296 TABLE 311 JAPAN: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 296 TABLE 312 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 297 TABLE 313 CHINA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 297 TABLE 314 CHINA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 298 TABLE 315 CHINA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 298 TABLE 316 CHINA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 298 TABLE 317 CHINA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 299 TABLE 318 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 319 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 299 TABLE 320 CHINA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 300 TABLE 321 CHINA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 300 TABLE 322 CHINA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 301 TABLE 323 CHINA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 301 TABLE 324 CHINA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 302 TABLE 325 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 302 TABLE 326 CHINA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 303 TABLE 327 CHINA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 303 TABLE 328 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 304 TABLE 329 INDIA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 305 TABLE 330 INDIA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 305 TABLE 331 INDIA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 305 TABLE 332 INDIA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 306 TABLE 333 INDIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 306 TABLE 334 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 335 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 307 TABLE 336 INDIA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 307 TABLE 337 INDIA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 308 TABLE 338 INDIA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 308 TABLE 339 INDIA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 309 TABLE 340 INDIA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 309 TABLE 341 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 310 TABLE 342 INDIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 310 TABLE 343 INDIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 310 TABLE 344 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 312 TABLE 345 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 312 TABLE 346 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 312 TABLE 347 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 313 TABLE 348 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 313 TABLE 349 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 313 TABLE 350 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 351 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 314 TABLE 352 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 315 TABLE 353 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 315 TABLE 354 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 316 TABLE 355 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 316 TABLE 356 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 317 TABLE 357 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 317 TABLE 358 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 318 TABLE 359 AUSTRALIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 318 TABLE 360 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 320 TABLE 361 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 320 TABLE 362 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 320 TABLE 363 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 321 TABLE 364 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 321 TABLE 365 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 321 TABLE 366 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 367 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 322 TABLE 368 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 323 TABLE 369 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 323 TABLE 370 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 324 TABLE 371 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 324 TABLE 372 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 325 TABLE 373 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 325 TABLE 374 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 326 TABLE 375 SOUTH KOREA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 326 TABLE 376 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 327 TABLE 377 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 327 TABLE 378 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 328 TABLE 379 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 328 TABLE 380 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 328 TABLE 381 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 329 TABLE 382 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 383 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 329 TABLE 384 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 330 TABLE 385 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 330 TABLE 386 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 331 TABLE 387 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 331 TABLE 388 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 332 TABLE 389 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 332 TABLE 390 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 333 TABLE 391 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 333 TABLE 392 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 335 TABLE 393 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 335 TABLE 394 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 335 TABLE 395 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 336 TABLE 396 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 336 TABLE 397 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 336 TABLE 398 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 337 TABLE 399 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 337 TABLE 400 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 337 TABLE 401 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 338 TABLE 402 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 338 TABLE 403 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 339 TABLE 404 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 339 TABLE 405 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 340 TABLE 406 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 340 TABLE 407 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 341 TABLE 408 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 341 TABLE 409 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 342 TABLE 410 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 343 TABLE 411 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 343 TABLE 412 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 343 TABLE 413 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 344 TABLE 414 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 344 TABLE 415 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 416 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 345 TABLE 417 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 345 TABLE 418 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 346 TABLE 419 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 346 TABLE 420 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 347 TABLE 421 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 347 TABLE 422 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 348 TABLE 423 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 348 TABLE 424 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 348 TABLE 425 MEXICO: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 349 TABLE 426 MEXICO: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 350 TABLE 427 MEXICO: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 350 TABLE 428 MEXICO: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 350 TABLE 429 MEXICO: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 351 TABLE 430 MEXICO: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 351 TABLE 431 MEXICO: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 432 MEXICO: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 352 TABLE 433 MEXICO: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 352 TABLE 434 MEXICO: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 353 TABLE 435 MEXICO: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 353 TABLE 436 MEXICO: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 354 TABLE 437 MEXICO: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 354 TABLE 438 MEXICO: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 355 TABLE 439 MEXICO: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 355 TABLE 440 MEXICO: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 355 TABLE 441 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 356 TABLE 442 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 357 TABLE 443 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 357 TABLE 444 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 357 TABLE 445 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 358 TABLE 446 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 358 TABLE 447 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 358 TABLE 448 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 359 TABLE 449 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 359 TABLE 450 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 360 TABLE 451 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 360 TABLE 452 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 361 TABLE 453 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 361 TABLE 454 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 362 TABLE 455 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 362 TABLE 456 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 362 TABLE 457 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 364 TABLE 458 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 364 TABLE 459 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 365 TABLE 460 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 365 TABLE 461 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 365 TABLE 462 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 366 TABLE 463 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 366 TABLE 464 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 366 TABLE 465 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 367 TABLE 466 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 367 TABLE 467 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 368 TABLE 468 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 368 TABLE 469 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 369 TABLE 470 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 369 TABLE 471 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 369 TABLE 472 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 370 TABLE 473 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 370 TABLE 474 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 475 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 371 TABLE 476 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 371 TABLE 477 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 372 TABLE 478 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 372 TABLE 479 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 373 TABLE 480 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 373 TABLE 481 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 374 TABLE 482 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 374 TABLE 483 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 374 TABLE 484 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 375 TABLE 485 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 376 TABLE 486 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 376 TABLE 487 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 376 TABLE 488 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 377 TABLE 489 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 377 TABLE 490 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 491 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 378 TABLE 492 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 378 TABLE 493 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 379 TABLE 494 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 379 TABLE 495 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 380 TABLE 496 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 380 TABLE 497 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 381 TABLE 498 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 381 TABLE 499 SAUDI ARABIA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 381 TABLE 500 UAE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 382 TABLE 501 UAE: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 383 TABLE 502 UAE: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 383 TABLE 503 UAE: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 383 TABLE 504 UAE: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 384 TABLE 505 UAE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 384 TABLE 506 UAE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 507 UAE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 385 TABLE 508 UAE: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 385 TABLE 509 UAE: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 386 TABLE 510 UAE: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 386 TABLE 511 UAE: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 387 TABLE 512 UAE: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 387 TABLE 513 UAE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 388 TABLE 514 UAE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 388 TABLE 515 UAE: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 388 TABLE 516 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 390 TABLE 517 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 390 TABLE 518 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 390 TABLE 519 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 391 TABLE 520 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 391 TABLE 521 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 391 TABLE 522 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 392 TABLE 523 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 392 TABLE 524 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 393 TABLE 525 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 393 TABLE 526 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 394 TABLE 527 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 394 TABLE 528 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 395 TABLE 529 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 395 TABLE 530 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 396 TABLE 531 REST OF GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 396 TABLE 532 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 397 TABLE 533 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 397 TABLE 534 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 398 TABLE 535 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 398 TABLE 536 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 398 TABLE 537 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 399 TABLE 538 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 539 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 399 TABLE 540 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 400 TABLE 541 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 400 TABLE 542 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 401 TABLE 543 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 401 TABLE 544 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 402 TABLE 545 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 402 TABLE 546 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 403 TABLE 547 SOUTH AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 403 TABLE 548 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 404 TABLE 549 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 404 TABLE 550 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 404 TABLE 551 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY MANAGED SERVICE, 2024–2031 (USD MILLION) 405 TABLE 552 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY PROFESSIONAL SERVICE, 2024–2031 (USD MILLION) 405 TABLE 553 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 405 TABLE 554 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 406 TABLE 555 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 406 TABLE 556 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2024–2031 (USD MILLION) 407 TABLE 557 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2024–2031 (USD MILLION) 407 TABLE 558 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL & ADMINISTRATIVE ANALYTICS, 2024–2031 (USD MILLION) 408 TABLE 559 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2024–2031 (USD MILLION) 408 TABLE 560 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY PATIENT JOURNEY & ENGAGEMENT ANALYTICS, 2024–2031 (USD MILLION) 409 TABLE 561 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2024–2031 (USD MILLION) 409 TABLE 562 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PROVIDER, 2024–2031 (USD MILLION) 410 TABLE 563 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY HEALTHCARE PAYER, 2024–2031 (USD MILLION) 410 TABLE 564 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET, 2023–MAY 2026 411 TABLE 565 HEALTHCARE ANALYTICS MARKET: DEGREE OF COMPETITION 414 TABLE 566 HEALTHCARE ANALYTICS MARKET: REGION FOOTPRINT 421 TABLE 567 HEALTHCARE ANALYTICS MARKET: COMPONENT FOOTPRINT 422 TABLE 568 HEALTHCARE ANALYTICS MARKET: APPLICATION FOOTPRINT 423 TABLE 569 HEALTHCARE ANALYTICS MARKET: END USER FOOTPRINT 424 TABLE 570 HEALTHCARE ANALYTICS MARKET: KEY STARTUPS/SMES 427 TABLE 571 HEALTHCARE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 428 TABLE 572 HEALTHCARE ANALYTICS MARKET: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS, 2023–MAY 2026 429 TABLE 573 HEALTHCARE ANALYTICS MARKET: DEALS, 2023–MAY 2026 431 TABLE 574 HEALTHCARE ANALYTICS MARKET: EXPANSIONS, 2023–MAY 2026 432 TABLE 575 MERATIVE: COMPANY OVERVIEW 433 TABLE 576 MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 434 TABLE 577 MERATIVE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 434 TABLE 578 MERATIVE: DEALS 435 TABLE 579 SAS INSTITUTE INC.: COMPANY OVERVIEW 437 TABLE 580 SAS INSTITUTE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 438 TABLE 581 SAS INSTITUTE INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 439 TABLE 582 OPTUM, INC.: COMPANY OVERVIEW 442 TABLE 583 OPTUM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 443 TABLE 584 OPTUM, INC.: PRODUCT LAUNCHES AND APPROVALS 445 TABLE 585 OPTUM, INC.: DEALS 446 TABLE 586 ORACLE: COMPANY OVERVIEW 448 TABLE 587 ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 450 TABLE 588 ORACLE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 452 TABLE 589 ORACLE: DEALS 453 TABLE 590 HEALTH CATALYST: COMPANY OVERVIEW 456 TABLE 591 HEALTH CATALYST: PRODUCTS/SOLUTIONS/SERVICES OFFERED 457 TABLE 592 HEALTH CATALYST: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 458 TABLE 593 HEALTH CATALYST: DEALS 460 TABLE 594 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW 462 TABLE 595 EXLSERVICE HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 463 TABLE 596 EXLSERVICE HOLDINGS, INC.: DEALS 465 TABLE 597 EXLSERVICE HOLDINGS, INC.: OTHER DEVELOPMENTS 465 TABLE 598 VERADIGM LLC: COMPANY OVERVIEW 468 TABLE 599 VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 469 TABLE 600 VERADIGM LLC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 470 TABLE 601 VERADIGM LLC: DEALS 471 TABLE 602 VERADIGM LLC: OTHER DEVELOPMENTS 472 TABLE 603 CITIUSTECH INC.: COMPANY OVERVIEW 474 TABLE 604 CITIUSTECH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 475 TABLE 605 CITIUSTECH INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 475 TABLE 606 CITIUSTECH INC.: DEALS 476 TABLE 607 CITIUSTECH INC.: EXPANSIONS 476 TABLE 608 CVS HEALTH: COMPANY OVERVIEW 477 TABLE 609 CVS HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 478 TABLE 610 CVS HEALTH: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 479 TABLE 611 CVS HEALTH: DEALS 479 TABLE 612 INOVALON: COMPANY OVERVIEW 481 TABLE 613 INOVALON: PRODUCTS/SOLUTIONS/SERVICES OFFERED 482 TABLE 614 INOVALON: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 483 TABLE 615 INOVALON: DEALS 483 TABLE 616 INOVALON: EXPANSIONS 484 TABLE 617 INOVALON: OTHER DEVELOPMENTS 484 TABLE 618 MCKESSON CORPORATION: COMPANY OVERVIEW 485 TABLE 619 MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 486 TABLE 620 MCKESSON CORPORATION: DEALS 487 TABLE 621 MEDEANALYTICS, INC.: COMPANY OVERVIEW 488 TABLE 622 MEDEANALYTICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 489 TABLE 623 MEDEANALYTICS, INC.: DEALS 490 TABLE 624 COTIVITI, INC.: COMPANY OVERVIEW 491 TABLE 625 COTIVITI, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 492 TABLE 626 DATAVANT INC.: COMPANY OVERVIEW 493 TABLE 627 DATAVANT INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 494 TABLE 628 DATAVANT INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 495 TABLE 629 DATAVANT INC.: DEALS 495 TABLE 630 DEFINITIVE HEALTHCARE, LLC: COMPANY OVERVIEW 497 TABLE 631 DEFINITIVE HEALTHCARE, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 498 TABLE 632 DEFINITIVE HEALTHCARE, LLC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 499 TABLE 633 DEFINITIVE HEALTHCARE, LLC.: DEALS 500 TABLE 634 KOMODO HEALTH, INC.: COMPANY OVERVIEW 501 TABLE 635 KOMODO HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 502 TABLE 636 KOMODO HEALTH, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 502 TABLE 637 KOMODO HEALTH, INC.: DEALS 503 TABLE 638 ATHENAHEALTH, INC.: COMPANY OVERVIEW 504 TABLE 639 ATHENAHEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 505 TABLE 640 ATHENAHEALTH, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 505 TABLE 641 ATHENAHEALTH, INC.: DEALS 507 TABLE 642 IQVIA: COMPANY OVERVIEW 508 TABLE 643 IQVIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 509 TABLE 644 IQVIA: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 510 TABLE 645 IQVIA: DEALS 511 TABLE 646 WIPRO: COMPANY OVERVIEW 512 TABLE 647 WIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 513 TABLE 648 CLOUDERA, INC.: COMPANY OVERVIEW 514 TABLE 649 CLOUDERA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 515 TABLE 650 CLOUDERA, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 516 TABLE 651 CLOUDERA, INC.: DEALS 517 TABLE 652 HEALTHVERITY, INC.: COMPANY OVERVIEW 518 TABLE 653 KYRUUS, INC.: COMPANY OVERVIEW 518 TABLE 654 HEALTHCORUM: COMPANY OVERVIEW 519 TABLE 655 LUMA HEALTH INC.: COMPANY OVERVIEW 519 TABLE 656 VALIDIC, INC.: COMPANY OVERVIEW 520 FIGURE 1 MARKET SCENARIO 51 FIGURE 2 HEALTHCARE ANALYTICS MARKET, 2024–2031 52 FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET 52 FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF HEALTHCARE ANALYTICS MARKET 53 FIGURE 5 HIGH-GROWTH SEGMENTS IN HEALTHCARE ANALYTICS MARKET 54 FIGURE 6 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 55 FIGURE 7 EXPANSION OF DECENTRALIZED AND REMOTE PATIENT-CENTRIC TRIALS TO DRIVE MARKET 56 FIGURE 8 HEALTHCARE PROVIDERS AND US ACCOUNTED FOR LARGEST MARKET SHARES IN 2025 57 FIGURE 9 JAPAN TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 58 FIGURE 10 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59 FIGURE 11 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS, 2009–2023 65 FIGURE 12 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2009–2023 66 FIGURE 13 HEALTHCARE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 75 FIGURE 14 HEALTHCARE ANALYTICS MARKET: VALUE CHAIN ANALYSIS 79 FIGURE 15 HEALTHCARE ANALYTICS MARKET: ECOSYSTEM ANALYSIS 81 FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 85 FIGURE 18 PATENT PUBLICATION TRENDS IN HEALTHCARE ANALYTICS MARKET, 2015–2026 98 FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR HEALTHCARE ANALYTICS MARKET 98 FIGURE 20 APPLIED AND GRANTED PATENTS IN HEALTHCARE ANALYTICS MARKET, JANUARY 2015–FEBRUARY 2026 99 FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 116 FIGURE 22 KEY BUYING CRITERIA, BY END USER 117 FIGURE 23 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT 208 FIGURE 24 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET SNAPSHOT 282 FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 413 FIGURE 26 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 414 FIGURE 27 BRAND/SOFTWARE COMPARISON 417 FIGURE 28 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 419 FIGURE 29 HEALTHCARE ANALYTICS MARKET: COMPANY FOOTPRINT 420 FIGURE 30 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 426 FIGURE 31 FINANCIAL METRICS (EV/EBITDA) 428 FIGURE 32 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 429 FIGURE 33 OPTUM, INC.: COMPANY SNAPSHOT (2025) 443 FIGURE 34 ORACLE: COMPANY SNAPSHOT (2024) 449 FIGURE 35 HEALTH CATALYST: COMPANY SNAPSHOT (2025) 457 FIGURE 36 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2025) 463 FIGURE 37 VERADIGM LLC: COMPANY SNAPSHOT (2022) 468 FIGURE 38 CVS HEALTH: COMPANY SNAPSHOT (2025) 478 FIGURE 39 MCKESSON CORPORATION: COMPANY SNAPSHOT (2025) 486 FIGURE 40 DEFINITIVE HEALTHCARE, LLC: COMPANY SNAPSHOT (2025) 498 FIGURE 41 IQVIA: COMPANY SNAPSHOT (2025) 509 FIGURE 42 WIPRO: COMPANY SNAPSHOT (2025) 513 FIGURE 43 RESEARCH DESIGN 521 FIGURE 44 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 527 FIGURE 45 BOTTOM-UP APPROACH 528 FIGURE 46 TOP-DOWN APPROACH 529 FIGURE 47 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 530 FIGURE 48 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 530 FIGURE 49 DATA TRIANGULATION 533

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們